Researchers from the Universities of Bath and Leeds (UK) have made a significant advance in the fight against malaria by uncovering a promising new potential target for drug discovery. The findings, ...

Inside every human cell, proteins are constantly being tagged with small chemical modifications after they're produced. Known ...

A Cytokinetics heart disease drug — already approved in one indication — succeeded in another Phase 3 trial, a potential boost for sales.

Researcher Jeffrey L. Cummings M.D., ScD, from the Kirk Kerkorian School of Medicine at UNLV, has released his annual report ...

Background Patients undergoing thoracoscopic pulmonary resection are prone to moderate-to-severe acute postoperative pain, ...

Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain. Researchers found that people regain weight faster after quitting these ...

LONDON, April 14 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab, which has fallen behind Eli Lilly (LLY.N), opens new tab in the immensely lucrative weight-loss drug market, said ...

AWS has now unveiled Amazon Bio Discovery, an AI platform that grants researchers direct access to a broad library of biological foundation models that can be fine-tuned for specific use cases in drug ...

There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in which the brain loses connection with the muscles, The ALS Association ...

CLEVELAND, Ohio — A recent clinical trial led by the University of Cincinnati looked at whether people living with HIV were more likely to take a monthly injection or a daily pill as treatment. The ...

March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of experimental drugs and adopt newer methods, such as computer ...